The evidence in our study and previous studies supported that SMPD1 variants increase the risk for PD, and then it may also suggest the potential role of the reduced ASMase activity in α-synuclein accumulation (Alcalay et al., 2019). Here, SMPD1 is linked to Parkinson disease.